Poly-pharmacology of existing drugs: How to crack the code? - Aix-Marseille Université Accéder directement au contenu
Article Dans Une Revue Cancer Letters Année : 2024

Poly-pharmacology of existing drugs: How to crack the code?

Résumé

Drug development in oncology is highly challenging, with less than 5% success rate in clinical trials. This alarming figure points out the need to study in more details the multiple biological effects of drugs in specific contexts. Indeed, the comprehensive assessment of drug poly-pharmacology can provide insights into their therapeutic and adverse effects, to optimize their utilization and maximize the success rate of clinical trials. Recent technological advances have made possible in-depth investigation of drug poly-pharmacology. This re- view first highlights high-throughput methodologies that have been used to unveil new mechanisms of action of existing drugs. Then, we discuss how emerging chemo-proteomics strategies allow effectively dissecting the poly- pharmacology of drugs in an unsupervised manner.
Fichier principal
Vignette du fichier
1-s2.0-S0304383524001939-main.pdf (2.79 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Licence : CC BY NC - Paternité - Pas d'utilisation commerciale

Dates et versions

hal-04539952 , version 1 (09-04-2024)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

Baptiste Mouysset, Marion Le Grand, Luc Camoin, Eddy Pasquier. Poly-pharmacology of existing drugs: How to crack the code?. Cancer Letters, 2024, 588, pp.216800. ⟨10.1016/j.canlet.2024.216800⟩. ⟨hal-04539952⟩

Collections

CNRS UNIV-AMU CRCM
24 Consultations
6 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More